January 3, 2018
Silke Otte brings more than 22 years of IT and financial services industry experience in digital channels, advertising, customer relationship management (CRM), campaign management, and concept development. Prior to joining Innoplexus, Silke Otte served as Chief Marketing Officer at paydirekt, where she was involved in the company building and responsible for the development of PR [...]
Scientifica’s new Sales and Marketing Director – Ed Saint
January 3, 2018
Scientifica is excited to announce Ed Saint is taking on the role of Sales and Marketing Director. Ed joined Scientifica in 2006 as a university intern, and has been involved in many different functions within the company. This has included marketing, sales and installation right through to business development. Most recently, Ed has been working [...]
Maravai LifeSciences Acquires Glen Research Corporation
January 3, 2018
SAN DIEGO -- Maravai LifeSciences ("Maravai"), a leader in providing specialty reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, today announced the acquisition of Sterling, VA based Glen Research Corporation ("Glen Research"). Founded in 1987, Glen Research is a recognized leader in providing a wide range of reagents used in the synthesis of DNA and RNA. Since its earliest [...]
New Platform to Accelerate the Delivery of Biotherapeutics
January 3, 2018
The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, today announced a collaboration to develop a novel analytical platform to improve the rapid analysis of the glycosylation profiles of biotherapeutics. This is a critical quality attribute which is important for the efficacy and safety of these molecules. The consortium brings [...]
Benchling Product: 2017 Year in Review
January 3, 2018
2017 was a big year for product development at Benchling. From launching four brand new modules, to adding over 200 features, to enhancing the experience for our 120,000+ loyal users, our developers innovated at a breathtaking pace that surpassed all industry standards. Now with the most comprehensive platform supporting all research modalities from early discovery [...]
SomaLogic closes $200M financing round
January 3, 2018
Nan Fung Life Sciences and Madryn Asset Management join iCarbonX in investing to accelerate SomaLogic’s unique precision health insights delivery business Boulder, CO – SomaLogic announced today that it has capped its $200 million funding round, anchored by iCarbonX with substantial investments from Nan Fung Life Sciences and Madryn Asset Management. The successful round will accelerate SomaLogic’s [...]
Highest Stability Recombinant Wnt3a for Organoid Culture
January 2, 2018
AMSBIO has introduced recombinant Wnt3a with a new Wnt stabilizer that significantly extends the activity of this protein in serum-free medium from a half-life of just 2 hours to around 30 hours. Wnt-3a is a protein that is encoded by the Wnt3a gene. The Wnt gene family consists of structurally related genes that encode secreted [...]
January 2, 2018
Rebranding efforts will provide customers with more and enhanced product offerings under a unified marketing message and align the way Lifecycle operates internally around its three major market divisions; Biopharmaceuticals, Industrial, and Regenerative Medicine FORT WORTH, Texas Lifecycle Biotechnologies, a leading supplier to the life science industry and parent company to Boval BioSolutions, Chata Biosystems [...]
DNAnexus Announces $58 Million Investment to Accelerate Expansion
January 2, 2018
Investment led by Foresite Capital with strategic investment by Microsoft will support expansion in translational informatics, clinical trials, and broadened use of biomedical data MOUNTAIN VIEW, Calif.--DNAnexus, Inc., the global leader in biomedical informatics and data management, today announced closing a $58 million financing led by new investor Foresite Capital with strategic investment from Microsoft [...]
BIO-TECHNE ACQUIRES ATLANTA BIOLOGICALS INC.
January 2, 2018
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) announced today that it has acquired all of the stock of Atlanta Biologicals, Inc. and its affiliated company, Scientific Ventures, Inc.. The transaction is financed through available cash on hand. Charles R. Kummeth, President and Chief Executive Officer of Bio-Techne, commented, "Atlanta Biologicals is a great fit with the Bio-Techne [...]

